Essex Woodlands Health Ventures as of June 30, 2017
Portfolio Holdings for Essex Woodlands Health Ventures
Essex Woodlands Health Ventures holds 9 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abiomed | 37.6 | $208M | 1.5M | 143.30 | |
| Revance Therapeutics (RVNC) | 21.9 | $121M | 4.6M | 26.40 | |
| Axogen (AXGN) | 14.7 | $81M | 4.9M | 16.75 | |
| Corium Intl | 12.6 | $70M | 9.4M | 7.46 | |
| Entellus Medical Cm | 9.7 | $54M | 3.2M | 16.56 | |
| Endologix | 2.1 | $12M | 1.3M | 9.30 | |
| MediciNova (MNOV) | 1.1 | $6.2M | 1.2M | 5.26 | |
| Acura Pharmaceuticals (ACUR) | 0.2 | $1.1M | 2.0M | 0.56 | |
| Catalyst Biosciences | 0.1 | $372k | 79k | 4.73 |
